Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Recent & Breaking News (TSX:BHC)

Bausch Health Announces Plans To Pursue An Initial Public Offering Of Solta Medical

PR Newswire August 3, 2021

Bausch Health To Reduce Debt By $350 Million

PR Newswire August 3, 2021

Bausch Health Completes Sale Of Amoun Pharmaceutical To ADQ

PR Newswire August 2, 2021

Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients

PR Newswire July 29, 2021

Salix Announces 2021 Gastrointestinal Health Scholars Program Winners

PR Newswire July 22, 2021

Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery

PR Newswire July 19, 2021

Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes

PR Newswire July 12, 2021

Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane)

PR Newswire July 7, 2021

Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3

PR Newswire July 6, 2021

Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations

PR Newswire July 1, 2021

Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses

Canada NewsWire June 23, 2021

Bausch Health Announces Extension Of Its Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021

PR Newswire June 22, 2021

Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors

PR Newswire June 21, 2021

Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE(TM) Clinical Decision Support Software

Canada NewsWire June 8, 2021

Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes

Canada NewsWire June 7, 2021

Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE(TM) (triamcinolone acetonide suprachoroidal injectable suspension)

Canada NewsWire June 2, 2021

Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month

Canada NewsWire June 1, 2021

Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

PR Newswire May 27, 2021

Bausch Health Announces Participation At The Jefferies Healthcare Conference

PR Newswire May 25, 2021

Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes

Canada NewsWire May 24, 2021